Ferroplex (Ferroplex)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceIron sulphate + Ascorbic acidIron sulphate + Ascorbic acid
Similar drugsTo uncover
  • Sorbifer Durules
    pills inwards 
    Egis Pharmaceutical Plant OJSC     Hungary
  • Fenules® 100
    pills inwards 
    Ranbaxy Laboratories Limited     India
  • Ferroplex
    pills inwards 
    Teva Pharmaceutical Enterprises Co., Ltd.     Israel
    • Dosage form: & nbspDragee.
    Composition:

    In one pills contains:

    Active substances: Ascorbic acid 30 mg. Iron (II) sulfate heptahydrate 50 mg.

    Excipients: lactose monohydrate, potato starch, sucrose, talc, stearin, gelatin.

    Sheath: sucrose, talc, magnesium oxide, vegetable oil, acacia gum (gum arabic).

    Description:

    Biconvex dragees are grayish-white or yellowish-white with a smooth shiny surface. At the break of grayish-beige color, the shell is white.

    Pharmacotherapeutic group:Iron preparation + Vitamin.
    ATX: & nbsp

    B.03.A.E.03   Iron preparations in combination with multivitamins

    Pharmacodynamics:

    The drug replenishes the iron deficiency in the body, which is necessary for the synthesis of hemoglobin. Ascorbic acid improves the absorption of iron. After taking the drug, iron absorption occurs mainly in the distal part of the small intestine. Absorption increases with a decrease in iron stores in the body.

    Indications:

    Prevention of iron deficiency conditions caused by pregnancy, lactation, acute and chronic blood loss, inadequate and unbalanced diet; in the period of convalescence after prolonged serious diseases and a period of intensive growth, as well as with a decrease in iron absorption in chronic diarrhea.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Disturbance of iron absorption (sideroachrestic anemia, lead anemia, pernicious anemia (insufficiency of vitamin B 12).

    Diseases accompanied by the accumulation of iron in the body (aplastic and hemolytic anemia, thalassemia, hemosiderosis, hemochromatosis).

    Condition after resection of the stomach, bleeding, children under 4 years.

    Carefully:

    Stomach ulcer and duodenal ulcer.

    Pregnancy and lactation:

    Dragee Ferroplex can be used to treat registered anemias with iron deficiency and also to prevent iron deficiency during pregnancy and lactation. However, continuous monitoring by a doctor and regular blood tests are recommended.

    Dosing and Administration:

    The drug is administered orally before meals.The duration of therapy is determined by the doctor individually.

    Adults - 2 tablets 3 times a day.

    Pregnant (II and III trimester of pregnancy) and lactating women with a prophylactic goal is recommended to take in a similar dose.

    Children from 4 to 12 years - 1 dragee 3 times a day.

    Dragee Ferroplex is recommended to be taken with a glass of water or fruit juice, preferably between meals (two hours before meals or one hour after meals) to improve absorption. Also, the drug can be taken with meals to reduce the occurrence of adverse gastrointestinal effects.

    It is not recommended to take pills with tea, coffee or milk, as they slow down the absorption of iron.

    Side effects:

    Gastralgia, nausea, vomiting, heartburn, constipation or diarrhea, decreased appetite, rarely skin allergic reactions.

    Overdose:

    Symptoms - nausea, vomiting, diarrhea. If there is a suspicion of overdose, it is necessary to carry out a study of the content of serum iron and serum ferritin, do a gastric lavage, assign milk and a raw egg to enhance the binding of iron ions, in the gastrointestinal tract and their subsequent excretion.In the case of a significant excess of normal serum ferritin levels, the appointment of an iron chelatordeferoxamine).

    Interaction:

    At simultaneous reception of Ferroplex with antacid preparations; colestyramine, methyldopa; preparations containing zinc, magnesium, calcium, phosphorus, aluminum; tetracycline antibiotics, chloramphenicol, penicillamine, ciprofloxacin, norfloxacin, ofloxacin, iron absorption deteriorates.

    Simultaneous reception of levothyroxine sodium with ferrous sulfate can lead to the formation of an insoluble iron-thyroxine compound, which reduces the absorption of thyroxin. Therefore, patients with primary hypothyroidism who receive levothyroxine sodium, should take levothyroxine sodium and iron with an interval of at least 2 hours, and the function of the thyroid gland should be checked regularly. Do not administer together with other iron preparations, including for parenteral use, to avoid overdose.

    Special instructions:

    Before starting therapy with iron, the serum iron, serum ferritin (ie, iron deficiency) should be examined.The drug should be treated prior to the normalization of the blood picture (8-12 weeks). When taking the drug, dark staining of the stool, false positive benzidine test is possible. It should be borne in mind that the use of tea in large quantities reduces the absorption of iron ions in the gastrointestinal tract.

    Form release / dosage:

    Dragee.

    Packaging:

    100 tablets in a glass jar with a polyethylene lid.

    Each bank along with the instruction for use is placed in a cardboard box.

    Storage conditions:

    At a temperature of no higher than 30 ° C in a dry, dark place. Keep out of the reach of children.

    Shelf life:

    5 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:П N013696 / 01
    Date of registration:29.09.2008
    The owner of the registration certificate:Teva Pharmaceutical Enterprises Co., Ltd.Teva Pharmaceutical Enterprises Co., Ltd. Israel
    Manufacturer: & nbsp
    Representation: & nbspTeva Teva Israel
    Information update date: & nbsp16.10.2015
    Illustrated instructions
      Instructions
      Up